QUINOLONES AS INHIBITORS OF CLASS IV BROMODOMAIN PROTEINS
申请人:UCL BUSINESS PLC
公开号:US20170291875A1
公开(公告)日:2017-10-12
The present invention provides compounds of formula (I) as described herein and pharmaceutically acceptable salts, hydrates and solvates thereof for use in medicine, for example in the treatment of acute myeloid leukaemia: